Life sciences industry executives are increasingly concerned they are not doing enough to attract and retain women in their organizations according to a new EY survey on industry-wide gender parity.
 |
The survey report—Navigating disruption without gender diversity? Think again—reveals that 53% of industry executives admit they are currently underutilizing women within their ranks. And yet, 72% of life sciences executives surveyed agree that having greater gender diversity at all levels of their business improves financial performance.
Announced in a press release, the survey suggests a looming threat of disruption facing the wider industry, as life sciences companies advance boldly into a digitally driven, patient-centric future. Challenged by this new environment, 73% of industry executives admit that dramatic changes are needed in how they attract, retain, engage, and promote talent.
In particular, life sciences executives are striving to achieve diversity of thought and experience within their leadership teams—something 57% say is currently lacking within their organizations. Overwhelmingly, 90% of industry executives agree that new leaders and leadership skills will make the difference in adapting to the disruptive changes impacting the sector.